• SENSEX 74,905.91
    376.83 (+0.51%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Meesho
    230.80 125.70(%)
  • Allied Blenders
    667.75 719.95(%)
  • Escorts Kubota
    2,828.00 3,998.95(%)
  • Molbio Diagnosti
    1,338.00 1,686.50(%)
  • Ather Energy
    1,484.00 535.00(%)
  • Swiggy
    278.20 235.85(%)
  • Kanohar Elect.
    938.00 905.50(%)
  • Glass Wall Syst.
    278.45 185.05(%)
  • Ola Electric
    42.32 59.20(%)
  • ICICI Bank
    1,344.70 1,479.90(%)
  • HDFC Bank
    742.80 1,020.35(%)
  • Cholaman.Inv.&Fn
    1,783.85 1,952.00(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Cupid
    273.00 298.95(%)
  • Solar Industries
    19,634.40 11,641.10(%)
  • Elecon Engg.Co
    476.90 628.45(%)
  • Britannia Inds.
    4,960.80 6,269.90(%)
  • Bluestone Jewel
    823.55 400.40(%)
  • Navin Fluo.Intl.
    8,360.05 4,500.10(%)
  • Eternal
    344.75 368.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Infinium Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 78690.0
  • ISIN : INE0MRE01011
262.20 -12 (-4.48%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    262.20

  • Today’s High

    278.95

  • Open

    278.95

  • Perv Close

    274.50

  • 52W Low

    189.40

  • 52W High

    285.50

Key Indicators

  • P/E(TTM)

    40.78

  • Mar.Cap (₹Cr.)

    408.59

  • Div & Yield %

    0.00

  • Book Value(₹)

    74.27

  • Debt-Equity Ratio

    -4.48

  • AGM Date

    22-Sep-2026

  • EPS

    6.43

  • P/E Ratio

    40.78

Financials Ratios

  • Debt-Equity Ratio

    0.50

  • Mar.Cap (₹Cr.)

    408.59

  • RONW (%)

    28.28

  • ROCE (%)

    28.57

Score Board

  • Equity (₹ in Cr.)

    15.58

  • BV (₹)

    74.30

  • Sales( ₹ in Cr.)

    156.45

  • NP (in Cr.)

    10.02

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    8.10

  • EPS (₹)

    6.40

  • Traded Value (₹ in Lakhs)

    408.59

  • 52 Week High

    285.50

  • 52 Week Low

    189.40

  • Price BSE

    0.0

  • Price NSE

    262.00

  • Market Capital( in Cr.)

    408.59

  • P/C Ratio

    32.40

  • P/E Ratio

    40.80

  • Price Vs.BV

    6.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 136.92 122.36 101.31 74.04 54.56 36.04
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 136.92 122.36 101.31 74.04 54.56 36.04
Other Income 2.13 1.63 1.34 0.93 0.62 0.57
Stock Adjustments -1.29 4.30 0.97 0.20 2.51 0.86
Total Income 137.76 128.29 103.62 75.17 57.69 37.47
EXPENDITURE :            
Raw Materials 107.87 98.01 71.53 54.22 41.98 28.30
Power and Fuel Cost 1.17 0.97 0.62 0.77 0.50 0.32
Employee Cost 5.03 4.56 3.67 3.16 2.21 1.85
Other Manufacturing Expenses 0.67 0.89 0.85 0.51 0.87 0.61
Selling and Administration Expenses 5.27 4.52 10.06 6.76 6.02 2.87
Miscellaneous Expenses 0.44 0.29 0.34 0.11 0.57 0.31
Employee Benefit Expenses 5.03 4.56 3.67 3.16 2.21 1.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 120.45 109.25 87.07 65.52 52.16 34.27
Operating Profit 17.31 19.05 16.55 9.65 5.53 3.20
Interest 2.72 1.78 3.00 1.66 1.12 1.23
Gross Profit 14.59 17.27 13.55 7.99 4.41 1.97
Depreciation 2.98 2.41 1.29 0.58 0.65 0.58
Profit Before Tax 11.61 14.86 12.26 7.41 3.76 1.39
Current Tax 3.25 3.65 3.10 1.91 1.05 0.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.12 0.11 0.02 -0.01 -0.01 0.00
Reported Net Profit 8.47 11.09 9.15 5.50 2.72 1.02
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 8.47 11.09 9.15 5.50 2.72 1.02
Adjustment below Net Profit 0.00 0.00 -3.30 0.00 0.00 -0.02
P & L Balance brought forward 27.71 16.62 10.77 5.26 2.54 1.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 36.18 27.71 16.62 10.77 5.26 2.53
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.43 7.97 18.00 54.13 26.75 10.01
Earnings Per Share(Adj)-Unit Curr 5.43 7.97 - - - -
Book Value 67.84 41.50 42.69 123.45 69.31 42.46
Book Value(Adj)-Unit Curr 67.84 41.50 - - - -

Shareholding Pattern

  • Promoter Group

    64.91%

  • Public Share Holding

    35.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 10,115,120 64.91 10,115,120 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,115,120 64.91 10,115,120 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 33,500 0.22 33,500 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 33,500 0.22 33,500 1
2] Non Institution
Bodies Corporate 20,500 0.13 20,500 8
Clearing Members 167,500 1.07 167,500 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 22,500 0.14 22,500 22
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 243,500 1.56 243,500 66
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,818,000 18.08 2,818,000 25
Individuals holding nominal share capital up to Rs. 1 lakh 2,162,500 13.88 2,162,500 918
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,434,500 34.87 5,434,500 1,043
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,583,120 100.00 15,583,120 1,061

Company Background

Infinium Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs

  • Infinium Pharmachem Ltd
  • BSE Code : 78690.0
  • ISIN : INE0MRE01011

  • Incorporation Year

    2003

  • Registered Office

    38 GIDC Sojitra
    Taluka-Sojitra, Anand,
    Gujarat-387240

  • Telephone

    91-2692-238849/238850/297446

  • FAX

  • Chairman

    Sanjaykumar Viththalbhai Patel

  • Managing Director

    Sanjaykumar Viththalbhai Patel

  • Company Secretary

    Nilesh Dharamshi Bhai Patel

  • Auditor

    Ashok Rajpara & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Infinium Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Infinium Pharma 262.20 139.05 136.92 40.78 13.22
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77